SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001626199-24-000012
Filing Date
2024-01-04
Accepted
2024-01-04 19:05:44
Documents
1
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1704413131.html 4  
1 FORM 4 wk-form4_1704413131.xml 4 4092
  Complete submission text file 0001626199-24-000012.txt   5762
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIELA BIO, INC., ONE MEDIMMUNE WAY FIRST FLOOR, AREA TWO GAITHERSBURG MD 20878
Business Address
Drappa Jorn (Reporting) CIK: 0001789317 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 24513927